作者: Giovanna Mantovani , Murat Bastepe , David Monk , Luisa De Sanctis , Susanne Thiele
DOI: 10.1038/S41574-018-0042-0
关键词: Parathyroid hormone 、 Type 2 Diabetes Mellitus 、 Neurocognitive 、 Medicine 、 Parathyroid Hormone Resistance 、 Short stature 、 Brachydactyly 、 Pseudohypoparathyroidism 、 Growth hormone deficiency 、 Pediatrics
摘要: This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) related disorders, which comprise metabolic disorders characterized by physical findings that variably include short bones, stature, a stocky build, early-onset obesity ectopic ossifications, as well endocrine defects often resistance to parathyroid hormone (PTH) TSH. The presentation severity PHP its vary between affected individuals considerable clinical molecular overlap different types. A specific is delayed owing lack recognition syndrome associated features. participants in this agreed should be based on major criteria, including PTH, brachydactyly obesity. laboratory confirmed genetic analysis. Patients screened at during follow-up features, such PTH resistance, TSH growth deficiency, hypogonadism, skeletal deformities, oral health, weight gain, glucose intolerance or type 2 diabetes mellitus, hypertension, subcutaneous and/or deeper ossifications neurocognitive impairment. Overall, coordinated multidisciplinary approach from infancy through adulthood, transition programme, help us improve care these disorders.